State of Wisconsin Investment Board
KNTE

State of Wisconsin Investment Board’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

State of Wisconsin Investment Board’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,500
Closed -$197K – 2896
2022
Q1 		$197K Hold
17,500
– – ﹤0.01% 2185
2021
Q4 		$310K Hold
17,500
– – ﹤0.01% 1936
2021
Q3 		$403K Buy
+17,500
New +$381K ﹤0.01% 1748

Other funds holding KNTE

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State of Wisconsin Investment Board's KNTE Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2022, closing a stake of 17,500 shares — an estimated $197K sold.

State of Wisconsin Investment Board first reported a position in KNTE in Q3 2021 and held it in 3 quarters. The position peaked at $403K in Q3 2021. 73 funds tracked by Wall St. Rank hold KNTE as of Q2 2022.

  • State of Wisconsin Investment Board reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 17,500 Kinnate Biopharma Inc. Common Stock shares in Q2 2022, an estimated $197K.
  • State of Wisconsin Investment Board first reported a position in Kinnate Biopharma Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • State of Wisconsin Investment Board's Kinnate Biopharma Inc. Common Stock position peaked at $403K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.